Mediherb
Cramplex 40 Tablets
Cramplex 40 Tablets
Regular price
$79.95 AUD
Regular price
Sale price
$79.95 AUD
Unit price
/
per
Description:
Cramplex is a combination of herbs used traditionally in Western herbal medicine for the relief of menstrual pain, cramping, and dysmenorrhoea.
Indications
-
Cramp Bark, Wild Yam root, and Ginger root are traditionally used in Western herbal medicine for the relief of menstrual pain, menstrual cramping, and dysmenorrhoea.
-
Cramp Bark is traditionally used in Western herbal medicine to:
- Relieve muscle cramps and relax the nervous system.
- For its antispasmodic activity.
Dose
Adults: 3-4 tablets 2 times daily.
Ingredients
Each tablet contains: | |
Corydalis turtschaninovii (Corydalis) extract | 60 mg |
Derived from tuber dry | 600 mg |
Zingiber officinale (Ginger) extract | 800 mcL |
Derived from rhizome dry | 400 mg |
Rubus idaeus (Raspberry) Extract | 800 mcL |
Derived from leaf dry | 400 mg |
Dioscorea villosa (Wild Yam) extract | 800 mcL |
Derived from root & rhizome dry | 400 mg |
Viburnum opulus (Cramp Bark) extract | 800 mcL |
Derived from stem bark dry | 400 mg |
Allergen Information
- No Added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds, artificial sweeteners, colours or flavours.
- Vegan friendly.
Excipients
Calcium hydrogen phosphate dihydrate, colloidal anhydrous silica, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycollate.
Warning
- Do not use if pregnant or likely to become pregnant.
- Daily doses of dried Ginger in excess of 4 g are contraindicated in patients who are already taking blood-thinning drugs such as warfarin or aspirin or who have an increased risk of haemorrhage. Exercise caution at doses of Ginger below this.
- When prescribing Ginger caution is advised in patients with gallstones.
- Contraindicated in patients taking nifedipine or crizotinib.
- Ginger should be used cautiously in patients taking antacids (it may decrease the effectiveness as Ginger increases gastric secretory activity) or phenprocoumon.
- Discontinue 7 days prior to general anaesthesia.
- If patient symptoms persist, seek additional professional advice.